Search
Lucid Diagnostics Inc
LUCDAdd to Watchlist
0.841USD
+0.055+7.00%
Market hours 09/21, 15:48（ET）
160.43MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+7.00%
5 Days
+7.41%
1 Month
-12.40%
6 Months
-32.72%
Year to Date
-22.84%
1 Year
-22.84%
Key Figures
0.790Open
0.850High
82.00KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.04%Turnover Ratio
0.786Prev. Close
0.778Low
66.56KTurnover
LossP/E Static
14.68P/B
0.00%Div Yield TTM
-134.61%ROA
1.62952wk High
0.06Volume Ratio
-53.02MNet Profit
190.76MShares
-0.3373EPS TTM
1.09Beta
-4989.67%ROE
0.75052wk Low
9.16%Amplitude
-5.16%Gross Margin
160.43MMarket Cap
-0.04Reward/Risk
3.84%Risk Rate
Lucid Diagnostics Inc's Score
0.16vs previous score
Forecast8.40
Financial Health6.03
Technical5.82
Valuation Dimensions7.73
Institutional Confidence3.00
Risk Assessment3.86
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Lucid Diagnostics Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Sell
Lucid Diagnostics Inc Latest Earnings Call Transcripts
Lucid Diagnostics (LUCD) Q2 2026 Earnings Call: Revenue Up 17%, Concert Coverage Advances
Lucid Diagnostics’ Q2 2026 earnings call covered $1.5 million revenue, 2,770 EsoGuard tests, Concert coverage, Medicare delays and $33.4 million cash.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.08/-0.07
Revenue / Forecast
1.47M/1.44M
Lucid Diagnostics Inc Profile
SectorHealthcare Equipment & Supplies
Ticker SymbolLUCD
Number of employees72
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| PAVmed Inc | 19.88% |
| Vanguard Capital Management, LLC | 2.13% |
| Masters Capital Management, L.L.C. | 2.05% |
| BlackRock Institutional Trust Company, N.A. | 2.01% |
| Shareholder Types | Proportion |
|---|---|
| Corporation | 19.88% |
| Investment Advisor | 6.74% |
| Individual Investor | 5.91% |
| Hedge Fund | 4.99% |
Related Instruments
-0.04%
-0.61%
+0.97%
+0.34%
+1.56%
+2.45%
-0.35%
-1.59%
-0.57%
+0.18%
-0.58%
-0.50%
+0.54%
+1.73%
+0.10%
+0.04%
-0.34%
+3.24%
-2.88%
+0.88%Popular Instruments
52095.400
+361.400 (+0.70%)
30515.300
+850.600 (+2.87%)
7770.700
+111.600 (+1.46%)
14601.000
+181.000 (+1.25%)
66608.000
+1529.000 (+2.35%)
6340.100
+109.300 (+1.75%)
92.076
-3.925 (-4.09%)
339.470
+3.340 (+0.99%)
227.380
+5.110 (+2.30%)
4346.250
-31.080 (-0.71%)
FAQs
What is the current price of Lucid Diagnostics Inc (LUCD)?
The current price of Lucid Diagnostics Inc (LUCD) is 0.79.
What is the symbol of Lucid Diagnostics Inc?
The ticker symbol of Lucid Diagnostics Inc is LUCD.
What is the 52-week high of Lucid Diagnostics Inc?
The 52-week high of Lucid Diagnostics Inc is 1.63.
What is the 52-week low of Lucid Diagnostics Inc?
The 52-week low of Lucid Diagnostics Inc is 0.75.
What is the market capitalization of Lucid Diagnostics Inc?
The market capitalization of Lucid Diagnostics Inc is 151.27M.
Is Lucid Diagnostics Inc (LUCD) currently rated as Buy, Hold, or Sell?
According to analysts, Lucid Diagnostics Inc (LUCD) has an overall rating of Buy, with a price target of 4.00.
What is the Earnings Per Share (EPS TTM) of Lucid Diagnostics Inc (LUCD)?
The Earnings Per Share (EPS TTM) of Lucid Diagnostics Inc (LUCD) is -0.34.